Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Mitiglinide calcium formulation and its detection method

A technology of mitiglinide calcium and its composition, which is applied in the field of preparations containing mitiglinide calcium and its quality control, which can solve the problems of large differences in loading, poor fluidity, and difficult operation, and reduce moisture absorption , Enhanced stability, increased fluidity

Inactive Publication Date: 2009-11-18
TIANJIN HANKANG PHARMA BIOTECH
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Miglinide calcium has the problem of instability, and it will degrade when left at room temperature for a certain period of time. At the same time, mitiglinide calcium also has a certain degree of hygroscopicity and poor fluidity. It is difficult to operate when making preparations. When filling capsules, Large differences in loading capacity affect product quality and shelf life

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mitiglinide calcium formulation and its detection method
  • Mitiglinide calcium formulation and its detection method
  • Mitiglinide calcium formulation and its detection method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0101] Preparation of tablets:

[0102] Miglinide Calcium 5g (in C 38 h 48 CaN 2 o 6 2H 2 O meter)

[0103] Lactose 160g

[0104] Mannitol 10g

[0105] Microcrystalline Cellulose 20g

[0106] Sodium carboxymethyl starch 10g

[0107] Sodium Lauryl Sulfate 1g

[0108] 5% starch slurry appropriate amount

[0109]

[0110] Makes 1000 pieces

[0111] The preparation method is:

[0112] The mitiglinide calcium is crushed through a 100-mesh sieve for later use, and the lactose, microcrystalline cellulose, mannitol, sodium carboxymethyl starch, and sodium lauryl sulfate are respectively passed through a 100-mesh sieve for later use.

[0113]Mix the above raw and auxiliary materials evenly, use 5% starch slurry to make soft material, and granulate with 24 mesh nylon mesh. Large granules need to be sieved and granulated to make them uniform granules; sieved with a 30-mesh sieve for granulation, and then pressed into tablets.

Embodiment 2

[0115] Preparation of capsules:

[0116] Miglinide Calcium 2.5g (in C 38 h 48 CaN 2 o 6 2H 2 O meter)

[0117] Lactose 80g

[0118] Mannitol 5g

[0119] Microcrystalline Cellulose 10g

[0120] Sodium carboxymethyl starch 5g

[0121] Sodium Lauryl Sulfate 0.5g

[0122] 5% starch slurry appropriate amount

[0123]

[0124] Makes 1000 capsules

[0125] The preparation method is:

[0126] The mitiglinide calcium is crushed through a 100-mesh sieve for later use, and the lactose, microcrystalline cellulose, mannitol, sodium carboxymethyl starch, and sodium lauryl sulfate are respectively passed through a 100-mesh sieve for later use.

[0127] Mix the above raw and auxiliary materials evenly, use 5% starch slurry to make soft material, and granulate with 24 mesh nylon mesh. Large granules need to be sieved and granulated to make them uniform granules; sieved with a 30-mesh sieve for granulation and packed into capsules.

Embodiment 3

[0129] Preparation of tablets:

[0130] Miglinide Calcium 10g (in C 38 h 48 CaN 2 o 6 2H 2 O meter)

[0131] Lactose 320g

[0132] Mannitol 20g

[0133] Microcrystalline Cellulose 40g

[0134] Sodium carboxymethyl starch 20g

[0135] Sodium Lauryl Sulfate 2g

[0136] 5% starch slurry appropriate amount

[0137]

[0138] Makes 1000 pieces

[0139] The preparation method is:

[0140] The mitiglinide calcium is crushed through a 100-mesh sieve for later use, and the lactose, microcrystalline cellulose, mannitol, sodium carboxymethyl starch, and sodium lauryl sulfate are respectively passed through a 100-mesh sieve for later use.

[0141] Mix the above raw and auxiliary materials evenly, use 5% starch slurry to make soft material, and granulate with 24 mesh nylon mesh. Large granules need to be sieved and granulated to make them uniform granules; sieved with a 30-mesh sieve for granulation, and then pressed into tablets.

[0142] ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a new formulation of mitiglinide calcium and its quality control method. The pharmaceutical composition of the invention is granulated by mixing mitiglinide calcium with lactose, mannitol, microcrystalline cellulose and sodium carboxymethyl starch Finally, the hygroscopicity is greatly reduced, the fluidity is increased, the dissolution is rapid, and the stability of the product is enhanced.

Description

Technical field: [0001] The invention relates to an antidiabetic drug preparation, in particular to a preparation containing mitiglinide calcium and a quality control method thereof. Background technique: [0002] Diabetes is a common and frequently-occurring disease, and the number of its patients is increasing rapidly with the improvement of people's living standards, population aging, changes in lifestyle, and advances in diagnostic techniques. According to the relevant data of WHO, the prevalence rate, disability rate, mortality rate and degree of harm of diabetes rank the third among non-communicable diseases, and it has become the third serious threat to human health after cardiovascular and cerebrovascular diseases and tumors. three diseases, [0003] At present, oral hypoglycemic agents clinically used for the treatment of type II diabetes are mainly sulfonylureas, biguanides, α-glucosidase inhibitors, thiazolidinediones, and meglitaides. Among them, insulin-secret...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/404A61K9/20A61K9/48A61K9/08A61K47/38A61P3/10
Inventor 严洁
Owner TIANJIN HANKANG PHARMA BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com